Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$5.89 - $9.73 $4.71 Million - $7.78 Million
-800,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$7.24 - $11.2 $15.9 Million - $24.6 Million
-2,200,000 Reduced 73.33%
800,000 $6.46 Million
Q1 2021

May 17, 2021

BUY
$8.05 - $20.78 $24.2 Million - $62.3 Million
3,000,000 New
3,000,000 $32.3 Million

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.